Key points
- Obeda is semaglutide made by Dr Reddy's, launched in India in March 2026.
- At launch it was approved for type 2 diabetes, not for weight management.
- It cost about ₹4,200 a month at launch, for the 2 mg and 4 mg pens.
- For weight loss, your doctor will usually choose a product approved for weight management.
What Obeda is
Obeda is a once-weekly semaglutide injection from Dr Reddy's Laboratories, approved by India's drug regulator (DCGI) and launched in March 2026, as soon as the semaglutide patent expired. It comes as a multi-dose pre-filled pen, in 2 mg and 4 mg pens.
Is Obeda for weight loss?
At launch, Obeda was approved for type 2 diabetes, and Dr Reddy's said it was seeking approval for weight management. That matters: a product approved only for diabetes isn't licensed for weight loss, even though the active medicine is the same as Wegovy. If you have type 2 diabetes and extra weight, your doctor may consider it. If you're looking for weight-loss treatment without diabetes, your doctor will usually choose a product approved for weight management.
Obeda price in India
At launch, Dr Reddy's priced Obeda at about ₹4,200 a month for both the 2 mg and 4 mg pens. Prices across semaglutide brands have changed since, so check the current MRP.
* Prices are manufacturers' maximum retail prices (MRP) in India, checked October 2026, and are shown as a guide only. Prices change often and may differ when you buy. Lean Life does not sell medicines online: any medicine is prescribed only after a consultation with a Lean Life doctor, and dispensed by a licensed pharmacy.
How Obeda compares
| Brand | Company | Approved for (at launch) | MRP per month |
|---|---|---|---|
| Semasize | Indian generic | Type 2 diabetes and weight management | ₹1,500 to ₹3,500 |
| Noveltreat | Sun Pharma | Weight management | about ₹3,600 to ₹8,000 at launch |
| Obeda | Dr Reddy's | Type 2 diabetes | about ₹4,200 at launch |
| Poviztra | Emcure (Novo Nordisk brand) | Weight management | ₹3,999 to ₹8,999 |
| Wegovy | Novo Nordisk | Weight management | ₹5,660 to ₹16,400 |
Getting Obeda safely
- Buy only with a prescription, from a licensed pharmacy. Never from social media sellers, gyms or salons.
- Check the pack is sealed, the batch number and expiry date are printed clearly, and the price is not far below MRP.
- Pens should arrive cold, in insulated packaging.
- If anything looks wrong, don't inject it. Show it to your pharmacist or doctor.
Questions
Is Obeda approved for weight loss?
At its March 2026 launch, Obeda was approved for type 2 diabetes. Dr Reddy's said it was seeking approval for weight management. Ask your doctor about its current status.
What is the price of Obeda?
About ₹4,200 a month at launch, for the 2 mg and 4 mg pens. Check the current MRP.
Is Obeda the same as Ozempic?
Both contain semaglutide and are approved for type 2 diabetes. Obeda is made by Dr Reddy's, Ozempic by Novo Nordisk, and the pens and prices differ.
Can I use Obeda for weight loss without diabetes?
Only if your doctor decides it's appropriate. Usually they'll choose a product approved for weight management.
References
- Dr Reddy's launches DCGI-approved semaglutide injection Obeda for type 2 diabetes, BioSpectrum India, March 2026
- Rs 325 to 4,200 a month: Dr Reddy's, Sun Pharma, Glenmark kick off generic semaglutide price war, ThePrint, March 2026
- Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med 2021
- Indian maximum retail prices checked October 2026
